These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 16358436)

  • 1. [Interstitial pneumonitis as a clinical manifestation in a patient with systemic sclerosis without scleroderma].
    Cubo Romano P; Mínguez García P; Muñoz Albarrán S; Abad Cardiel M; Pontes Navarro JC
    An Med Interna; 2005 Aug; 22(8):402-3. PubMed ID: 16358436
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diffuse interstitial pneumonia revealing systemic sclerosis sine scleroderma].
    Baili L; Aydi Z; Rachdi I; Ben Dhaou B; Boussema F; Rokbani L
    Tunis Med; 2014 Jul; 92(7):508-10. PubMed ID: 25775296
    [No Abstract]   [Full Text] [Related]  

  • 3. Interstitial lung disease as the first manifestation of systemic sclerosis.
    van der Kamp R; Tak PP; Jansen HM; Bresser P
    Neth J Med; 2007 Nov; 65(10):390-4. PubMed ID: 18057462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Renal disease in a patient with systemic sclerosis].
    Frikha F; Bahloul Z
    Pan Afr Med J; 2015; 21():257. PubMed ID: 26523192
    [No Abstract]   [Full Text] [Related]  

  • 5. Gastroesophageal reflux and lung disease in systemic sclerosis.
    Carlo-Stella N; Belloli L; Barbera R; Gambaro C; Rando G; Malesci A; Marasini B
    Am J Respir Crit Care Med; 2009 Jun; 179(12):1167; author reply 1167-8. PubMed ID: 19498067
    [No Abstract]   [Full Text] [Related]  

  • 6. A case of systemic sclerosis with sarcoidosis.
    Suga H; Asano Y; Tamaki Z; Yamamoto M; Sugaya M; Shimizu J; Sato S
    Acta Derm Venereol; 2011 Oct; 91(6):718-20. PubMed ID: 21681357
    [No Abstract]   [Full Text] [Related]  

  • 7. [Systemic sclerosis with advanced cardio-pulmonary compromise].
    Villa R; Panico N; Oliveri C; Bezante G; Brusasco V; Indiveri F
    Ann Ital Med Int; 2005; 20(2):118-32; quiz 133-5. PubMed ID: 16052846
    [No Abstract]   [Full Text] [Related]  

  • 8. Scleroderma lung: pathogenesis, evaluation, and current therapy.
    Co HT; Block JA; Sequeira W
    Am J Ther; 2000 Sep; 7(5):321-4. PubMed ID: 11317180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful use of intravenous cyclophosphamide pulse therapy for interstitial lung disease in a patient with systemic sclerosis on hemodialysis.
    Takahashi T; Asano Y; Sunaga R; Ichimura Y; Taniguchi T; Yamamoto M; Tamaki Z; Takekoshi T; Mitsui H; Sugaya M; Ohse T; Sato S
    J Dermatol; 2014 Jun; 41(6):533-5. PubMed ID: 24814462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desquamative interstitial pneumonia as the initial manifestation of systemic sclerosis.
    Swartz JS; Chatterjee S; Parambil JG
    J Clin Rheumatol; 2010 Sep; 16(6):284-6. PubMed ID: 20808169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interstitial pneumonia preceding systemic sclerosis].
    Imokawa S; Sato A; Sato J; Tsukamoto K; Todate A; Toyoshima M; Suda T; Hayakawa H; Chida K; Iwata M
    Nihon Kokyuki Gakkai Zasshi; 1998 Nov; 36(11):969-72. PubMed ID: 9916482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. European consensus reached on interstitial lung disease in SSc.
    Clarke J
    Nat Rev Rheumatol; 2020 Mar; 16(3):127. PubMed ID: 32001824
    [No Abstract]   [Full Text] [Related]  

  • 13. Interstitial lung disease in scleroderma.
    Schoenfeld SR; Castelino FV
    Rheum Dis Clin North Am; 2015 May; 41(2):237-48. PubMed ID: 25836640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B cell infiltration in systemic sclerosis-associated interstitial lung disease.
    Lafyatis R; O'Hara C; Feghali-Bostwick CA; Matteson E
    Arthritis Rheum; 2007 Sep; 56(9):3167-8. PubMed ID: 17763433
    [No Abstract]   [Full Text] [Related]  

  • 15. Systemic sclerosis-associated interstitial lung disease treated with tocilizumab.
    Dauny V; Borie R; Forien M; Ghanem M; Palazzo E; Jelin G; Dieudé P; Ottaviani S
    Intern Med J; 2021 Jun; 51(6):999-1000. PubMed ID: 34155759
    [No Abstract]   [Full Text] [Related]  

  • 16. One-step closer to solve the mystery of predicting disease progression in systemic sclerosis associated interstitial lung disease?
    Hoffmann-Vold AM; Kreuter M
    Thorax; 2021 Dec; 76(12):1170-1171. PubMed ID: 34446525
    [No Abstract]   [Full Text] [Related]  

  • 17. Detection of Systemic Sclerosis-associated Interstitial Lung Disease by Exhaled Breath Analysis Using Electronic Nose Technology.
    Marges ER; van der Sar IG; de Vries-Bouwstra JK; Huizinga TWJ; van Daele PLA; Wijsenbeek MS; Moor CC; Geelhoed JJM
    Am J Respir Crit Care Med; 2024 Aug; 210(4):512-514. PubMed ID: 38843104
    [No Abstract]   [Full Text] [Related]  

  • 18. Association Between Immunosuppressive Therapy and Incident Risk of Interstitial Lung Disease in Systemic Sclerosis.
    Hoa S; Bernatsky S; Baron M; Proudman S; Stevens W; Sahhar J; Wang M; Steele RJ; ; ; Nikpour M; Hudson M
    Chest; 2021 Dec; 160(6):2158-2162. PubMed ID: 34153341
    [No Abstract]   [Full Text] [Related]  

  • 19. Nintedanib for systemic sclerosis-associated interstitial lung disease.
    Rahimi S
    Lancet Respir Med; 2020 Feb; 8(2):136. PubMed ID: 31932219
    [No Abstract]   [Full Text] [Related]  

  • 20. [Efficacy of mycophenolate associated with methotrexate as a maintenance treatment for systemic sclerosis-associated interstitial lung disease].
    Gonzalez-Nieto JA; Martin-Suarez IJ; Gil-Muñoz FL
    Arch Bronconeumol; 2011 Nov; 47(11):575. PubMed ID: 21821334
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.